Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if eplerenone is effective in the treatment of mild to moderate heart failure
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT00181259 · Heart Failure, Congestive
NCT00733590 · Heart Failure, Congestive, Death, Sudden, Cardiac, and more
NCT00400985 · Heart Failure, Congestive
NCT05168722 · COVID-19 Pandemic, Pulmonary Disease, Chronic Obstructive, and more
NCT03237858 · Heart Failure, Congestive
Pfizer Investigational Site
Castro Valley, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
Santa Rosa, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions